Key facts
- Clear Labs’s last known valuation is $413.0M (Dec 2024).
- It has raised $173.3M across 4 recorded rounds; the latest was Early Stage VC ($29.1M) in Dec 2024.
- Notable investors include Plug and Play Tech Center, Alumni Ventures, Khosla Ventures, GV, Menlo Ventures — 31 tracked in total.
- Clear Labs has filed 5 Form Ds with the SEC since 2015, most recently Dec 2024 ($29.1M sold to 33 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 31 names
- ·Watchlist + deal alerts for Clear Labs
Funding rounds
4 roundsAbout Clear Labs
Developer of a comprehensive whole-genome sequencing platform intended to enhance pathogen surveillance and infectious disease outbreak management. The company's platform integrates automated sequencing with advanced bioinformatics, facilitating rapid detection and analysis of pathogens, enabling public health agencies and food safety organizations to improve response times and ensure consumer safety through precise genomic insights.
- Sector
- Healthcare
- HQ
- San Carlos, CA, United States
- Founded
- 2014
- Employees
- 83
- Website
- clearlabs.com/
- Ownership
- Privately Held (backing)
Clear Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Clear Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Clear Labs in its N-PORT filings yet. We sweep new filings monthly.